Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Lumos Diagnostics Holdings Ltd

Healthcare AU LDX

0.305AUD
0.02(7.02%)

Last update at 2026-03-11T05:10:00Z

Day Range

0.280.32
LowHigh

52 Week Range

0.020.33
LowHigh

Fundamentals

  • Previous Close 0.28
  • Market Cap234.00M
  • Volume5794849
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-10.57700M
  • Revenue TTM12.21M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 7.59M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -7.18300M -8.59200M -8.97100M -45.72400M -20.12700M
Minority interest - - - - -
Net income -7.18300M -8.59200M -8.97100M -45.72400M -20.12700M
Selling general administrative 11.99M 10.45M 10.22M 16.86M 22.21M
Selling and marketing expenses 0.50M 0.29M - 2.27M -
Gross profit 7.91M 7.10M 5.97M 4.46M 11.52M
Reconciled depreciation 2.53M 2.65M 3.67M 2.82M -
Ebit -7.16300M -8.08500M -10.23600M -21.49400M -11.00200M
Ebitda -4.63500M -5.43600M -4.92900M -18.67100M -
Depreciation and amortization 2.53M 2.65M - 2.82M -
Non operating income net other - - - - -
Operating income -7.84200M -7.12200M -9.52700M -21.49400M -14.56600M
Other operating expenses 20.34M 18.25M - 32.70M 0.66M
Interest expense 0.02M 0.97M 0.37M 0.17M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.06M 0.04M 0.02M 0.61M 3.02M
Net interest income -0.52600M -1.07100M -0.79100M -0.61000M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.96300M - 0.19M -
Total revenue 12.50M 11.13M 10.54M 11.63M 25.05M
Total operating expenses 15.75M 14.22M - 25.53M -
Cost of revenue 4.59M 4.03M 4.56M 7.17M 13.53M
Total other income expense net 0.66M -1.47000M 1.35M -24.04100M -
Discontinued operations - - - - -
Net income from continuing ops -7.18300M -8.59200M -8.97100M -45.72400M -
Net income applicable to common shares -7.18300M -8.59200M -8.97100M -45.72400M -15.03000M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 20.81M 26.84M 25.42M 36.94M 130.55M
Intangible assets 8.18M 9.69M 10.89M 12.53M 32.91M
Earning assets - - - - -
Other current assets 2.32M 1.01M - 1.05M -
Total liab 14.65M 19.73M 15.92M 19.05M 52.82M
Total stockholder equity 6.16M 7.11M 9.50M 17.89M 77.73M
Deferred long term liab - - 7.19M 8.15M 8.76M
Other current liab 3.07M 12.08M 3.46M 10.41M 25.21M
Common stock - 98.23M 92.47M 92.14M 84.22M
Capital stock 103.96M - 92.47M 92.14M -
Retained earnings -97.84100M -90.86000M -82.29200M -74.53400M -28.81000M
Other liab - - - - -
Good will - - - 0.00000M 1.47M
Other assets - - 7.19M 8.15M 8.76M
Cash 1.96M 6.48M 3.02M 7.98M -
Cash and equivalents - - - 7.98M 44.89M
Total current liabilities 8.71M 12.62M 8.17M 12.83M 32.51M
Current deferred revenue - - - 3.75M -
Net debt - -6.47900M - -0.78400M -
Short term debt - - - 0.97M 0.00000M
Short long term debt - - 1.35M - -
Short long term debt total - - - 7.19M -
Other stockholder equity - - -0.67800M 0.28M 2.87M
Property plant equipment - - 8.56M 10.97M 14.88M
Total current assets 6.46M 9.56M 5.96M 13.44M 57.06M
Long term investments - - - - -
Net tangible assets - - 5.80M 13.50M 41.20M
Short term investments - - - - -
Net receivables 1.04M 0.67M 1.49M 1.89M 4.25M
Long term debt - - - - -
Inventory 0.52M 0.78M 1.06M 2.53M 4.44M
Accounts payable 1.37M 0.55M 1.14M 1.45M 4.56M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.25900M - 0.28M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 14.35M 17.28M 19.45M 23.50M -
Capital lease obligations 6.99M - 8.44M 7.19M -
Long term debt total - - - 6.23M 9.57M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.05300M -0.09800M 4.31M -4.35500M -
Change to liabilities - - -6.17800M -3.09500M 8.33M
Total cashflows from investing activities -0.05300M -0.09800M 4.31M -4.35500M -8.33200M
Net borrowings - -1.11000M 0.79M -1.20600M 16.26M
Total cash from financing activities 5.28M 2.63M 0.65M -10.91900M 63.27M
Change to operating activities - - 0.50M 1.54M -0.47900M
Net income -7.18300M -8.59200M -8.97100M -45.72400M -15.03000M
Change in cash -4.52300M 3.46M -4.96300M -36.91200M 44.04M
Begin period cash flow 6.48M 3.02M 7.98M 44.89M -
End period cash flow 1.96M 6.48M 3.02M 7.98M 44.89M
Total cash from operating activities -9.33400M 0.95M -9.63800M -18.03600M -10.88900M
Issuance of capital stock 6.22M 5.00M - 7.87M -
Depreciation - 3.15M 3.03M 2.42M 0.45M
Other cashflows from investing activities - -0.04600M - - -
Dividends paid - - - - -
Change to inventory 0.26M 0.28M 0.81M -1.35400M -3.93900M
Change to account receivables -0.37300M 0.81M 0.93M -0.18000M -3.32600M
Sale purchase of stock 6.22M 5.00M - -9.71300M 57.81M
Other cashflows from financing activities - -1.25900M -0.13400M -18.78900M 17.58M
Change to netincome - - -0.73700M 27.95M 3.01M
Capital expenditures 0.05M 0.10M 0.12M 4.36M 5.88M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.46500M 0.05M - 0.02M 0.00600M
Stock based compensation - 0.45M - - -
Other non cash items -7.86900M 5.89M - - -
Free cash flow -9.38700M 0.85M -9.79300M -4.35500M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LDX
Lumos Diagnostics Holdings Ltd		 0.02 7.02% 0.30 - - 19.16 26.80 13.71 -0.3297
COH
Cochlear Ltd		 0.89 0.49% 183.41 35.04 28.33 5.17 6.50 5.41 22.39
4DX
4DMEDICAL Ltd		 -0.05 1.13% 4.38 - - 421.18 37.59 411.50 -7.2899
AVR
Anteris Technologies Global Corp		 0.27 3.14% 8.86 - - 495.24 162.25 283.45 -5.1986
PNV
Polynovo Ltd		 0.05 5.56% 0.95 92.50 30.40 4.58 7.52 4.45 89.43

Reports Covered

Stock Research & News

View All

Profile

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

Lumos Diagnostics Holdings Ltd

2724 Loker Ave West, Carlsbad, CA, United States, 92010

Key Executives

Name Title Year Born
Mr. Samuel Lanyon Exec. Chairman NA
Mr. Douglas Ward Chief Exec. Officer NA
Mr. Barrie Lambert Chief Financial Officer NA
Dr. Sacha Dopheide Ph.D. Chief Technology Officer NA
Ms. Jennifer Christiansen VP of Corp. Marketing & Communications NA
Ms. Sarah Glubka Sr. Director of HR NA
Ms. Annie Bell Sr. Director of Medical Affairs NA
Ms. Sue Hibbeln Sr. Director of Regulatory Affairs NA
Mr. Paul Kase Sr. VP of Commercial Operations NA
Ms. Melanie Jaye Leydin B.Bus, C.A., CA Company Sec. 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.